AI cardiac ultrasound company
UltraSight has raised €11M across 1 funding round from 3 investors, most recently a Series B round in May 2021. Based in Israel; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-05-14 | Series B |
| €11M |
| Atain Specialty Insurance,Weizmann Institute of Science,Yozma Group Korea |
| View deal → |
